“Rising Demand for Human Milk Oligosaccharides (HMOs)”
- HMOs are increasingly recognized as vital for infant health, mirroring breastfeeding advantages. These understanding drives parental interest in formulas enriched with these components
- For instance, a widely shared parenting blog in India (early 2025) highlighted HMOs for strong infant immunity, referencing Mumbai conference findings. This increased parental awareness and demand
- Parents in urban centers such as Gurugram and Bangalore increasingly choose premium HMO-enriched formulas despite higher costs. They prioritize advanced nutrition for their babies' well-being
- For instance, Online baby product retailers in India reported a consistent sales surge for HMO formulas in Q1 2025 compared to last year. This reflects a clear consumer preference
- Innovations in biotechnology are making a broader range of HMOs commercially accessible and sustainable. This allows manufacturers to incorporate diverse HMOs into their products
- Emerging studies continuously highlight the diverse health advantages of different HMO structures for infants. This scientific validation further strengthens the case for their inclusion in infant formula
- Major infant formula brands are actively expanding their product lines to include HMO-enriched options. This reflects the industry's response to consumer demand and scientific progress
